Wyeth in-licenses Intercell adjuvant

Intercell (VSE:ICLL) granted WYE non-exclusive worldwide rights to IC31, a synthetic adjuvant, for use in infectious disease vaccines. ICLL could receive up to $77 million in upfront, option and miles...